Alnylam Pharmaceuticals is looking for an imaginative physician drug developer to lead clinical development of RNAi therapeutics with a focus on autoimmune liver diseases. The successful candidate will have significant leadership responsibilities, extensive collaboration with cross-functional teams, and must possess an MD or MD PhD along with 10+ years of industry experience. This hybrid role is based in Maidenhead or Cambridge, UK, offering a dynamic environment focused on innovative drug development.
#J-18808-Ljbffr